Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "We sell Ranbaxy Laboratories. It is not participating; it is cracking all kind of support levels. There is nothing there. Avoid it or sell it."
At 11:13 hrs Ranbaxy Laboratories was quoting at Rs 350.70, down Rs 14.70, or 4.02 percent. It has touched a 52-week low of Rs 350.10.
The share touched its 52-week high Rs 578.30 and 52-week low Rs 357.20 on 04 September, 2012 and 04 June, 2013, respectively. Also Read: DIPP to send proposal to PMO on review of pharma FDI policy
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
